Aaron Sato, Chief Strategy Officer, will present Adimab's journey from startup to leading antibody platform.

William Roach hosts a table discussion on challenges and solutions in bi- and multispecific antibodies.

Brad Lunde and Aaron Sato moderate panel discussions for multispecifics and peptides.

Bringing the antibody therapeutics community together for thoughtful conversation and connection.

Garrett Rappazzo will present "Specificity of rare high-affinity human TCRs derived from synthetic yeast-based libraries."